Quality Assurance Scheme Development Group
The Quality Assurance Scheme Development Group (QASDG) will develop the European Quality Assurance Scheme for Breast Cancer Services (the European QA scheme) to set common quality and safety requirements for person-centred breast cancer services in Europe. The scheme will cover all the processes of breast cancer care (screening, diagnosis, treatment, rehabilitation & supportive care, follow-up & survivorship care and palliative care) and will be underpinned by the accreditation legal framework and evidence from guidelines.
The QASDG discusses and selects the requirements within virtual working environments and in meetings organised every three months. The initial draft documents and the final versions before piloting are subject of open calls for feedback launched online. After piloting, the so validated scheme will become operative on voluntary basis throughout Europe.
The members are also invited to contribute to the other ECIBC objectives, the Digital Mammography Training Template and the European Guidelines Platform covering all processes of care (from screening to end-of-life care).
The QASDG is supported by the external contractors EA- European Co-operation for Accreditation for the accreditation legal framework and for the coordination of national accreditation bodies, by CCIb –Iberoamerican Cochrane Centre for literature review and by IQ healthcare to develop indicators.
Members and external experts
Professor of Pathology at the University of Trieste. Head of the Molecular Histopathology Laboratory.
Prof. Giorgio Stanta is especially interested in molecular analysis in clinical tissues (Fixed and Paraffin Embedded Tissues) for diagnostics and clinical research. He is especially involved in studies about preanalytical conditions, methods standardization, external and internal quality assurance, tumour heterogeneity.
Coordinator of the European group IMPACTS (20 institutions from 11 countries), interested in validation and standardization of molecular analysis in archive tissues. In 2011 the participants in the IMPACTS group published a multiauthor book: “Guidelines for Molecular Analysis in Archive Tissues”, of which Prof. Stanta is the editor. It is one of the top selling books of Springer publishing.
Chairman of the “Biobanking and Molecular Pathobiology Working Group” of the Organisation of European Cancer Institutes (OECI).
Chairman of the “Molecular Pathology Working Group” of the European Society of Pathology (ESP).
Chairman of the “Archive Tissue Working Group of BBMRI-ERIC” (Biobanking and Biomolecular Resources Research Infrastructure).
Member of the European Society of Medical Oncology (ESMO) faculty for the Cancer Genetics group.
Member of the managing board for the network of Italian biobanks (BBMRI.IT) and coordinator of the Italian network of archive tissue biobanks (NIPAB), which collaborates with SIAPEC (the Italian society of pathologists) to set up the network.Part of the Committee of CEN (European Committee for Standardization) for Molecular in-vitro diagnostic examinations — Specifications for pre-examination processes for fresh tissues, FFPE tissues, blood for DNA, RNA and proteins, technical specifications to ISO 15189.